Journey Medical Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -188.1% | – | – | – | – | -227.3% | – | – | – | – | -159.6% | – | |
| – | +0.2% | -0.2% | +0.4% | -0.2% | +19.8% | +8.3% | +0.0% | +0.0% | +0.2% | +5.6% | -15.7% | – | |
| – | -5.2% | +165.8% | +19.1% | -2.0% | -16.0% | -4.0% | +1.0% | +38.8% | -4.3% | -44.3% | +45.3% | – | |
| – | -3,917.3% | – | -245.8% | – | – | – | – | -528.2% | – | – | -300.4% | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -105.1% | -100.0% | – | – | -100.0% | – | – | |
| – | – | -91.5% | +207.3% | -105.8% | – | -66.1% | -95.4% | +4,165.5% | -22.9% | -95.9% | -28.2% | – | |
| – | -65.4% | -225.7% | – | – | – | – | -201.6% | – | -118.4% | – | -150.4% | – | |
| – | -188.1% | – | – | – | – | -227.3% | – | – | – | – | -159.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.